Friday, May 20, 2011
Coeliac disease vaccine shows promise
Coeliac disease vaccine shows promise
The world's first potential vaccine for coeliac disease has shown promising results for treating coeliac disease in a Phase I clinical trial and is expected to move to Phase II trials within the next year.
The Phase I trial undertaken in Melbourne, Australia, evaluated the safety, tolerability and bioactivity of the vaccine Nexvax2®, which has been developed for coeliac disease. Coeliac disease is an
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment